Treatment of Advanced Cancer-related Lymphocytopenia: Comparison among the Effects of Subcutaneous Low-dose Interleukin-2, High-dose Pineal Hormone Melatonin and Checkpoint Inhibitors
The Onco-genomic Landscape of Malignant Melanoma: The Tumor Microenvironment comes of Age